/Investor DB

Coddle Creek Capital

Venture capital

Kannapolis · Pre-Seed–Seed · 15 people tracked

Find your way into Coddle Creek Capital

Sign up to see every warm intro you have to Coddle Creek Capital

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Coddle Creek Capital team. We find them for you
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

Coddle Creek Capital invests in and actively builds early stage life science companies, combining cutting-edge science, professional founders, and investment capital. It focuses on the life sciences sub-sectors of genomics, nutrition, immunology, oncology, microbiome, and neurology. The firm takes a hands-on management approach: securing a commercial management team, seeding the team, helping it attract strategic investors and partners, and leading capital markets fundraising efforts.

Source: firm website, verified Oct 2, 2026.

Stage
Pre-Seed–Seed
Check
$150K – $650K
HQ
Kannapolis, North Carolina, US
Instruments
Equity
Founded
2018

Team · 15 people

from the firm's website
Charlene Kuo· General Partnerin
David Helmer· General Partner
Fred Chasalow· Founder, AMUR Research

Founder of AMUR Research (acquired by SuperGen), former AVP at Morgan Stanley and former professor of pediatrics at SUNY Brooklyn.

Jason Colgate· General Partnerin
John Allen· General Partnerin
John Powderly· Founder, President - Carolina BioOncology Institute & BioCytics Human Applications Lab

Founder and president of the Carolina BioOncology Institute and BioCytics Human Applications Lab.

Tomoko Maeda-Chubachi· CMO, Pelthos Therapeutics; Founder, TMC Clinical Development Consulting

Chief Medical Officer at Pelthos Therapeutics and founder of TMC Clinical Development Consulting, with former leadership roles at GSK, Eli Lilly, Novan, and Pfizer.

Leah Allen· Partner, Director of Community Outreachin
Brian Smith· Chief Financial Officerin
Bryan Chuprinko· IP Development Program Managerin
Cole Nelson· Senior Research Analystin
Jeffrey Glenn· Professor of Medicine - Gastroenterology, Hepatology, Microbiology, Immunology at Stanford

Advisor and professor of medicine at Stanford specializing in gastroenterology, hepatology, microbiology, and immunology.

Lance Ramsey· Director of Risk Managementin
Russ Weiker· Associate, Business Developmentin
Susan Sumner· Director of the Metabolomics and Exposome Laboratory (MEL), UNC Chapel Hill

Directs the Metabolomics and Exposome Laboratory at UNC Chapel Hill.

Frequently asked questions

What stage does Coddle Creek Capital invest at?
Coddle Creek Capital invests at the Pre-Seed, Seed stages.
What is Coddle Creek Capital's typical check size?
Coddle Creek Capital typically writes checks of $150K – $650K.
What sectors does Coddle Creek Capital focus on?
Coddle Creek Capital focuses on Biotech, Healthtech, Longevity, Medical Devices.
Where is Coddle Creek Capital located?
Coddle Creek Capital is headquartered in Kannapolis, US.

Media · Podcasts & interviews

featuring the team

5 Award Winning Minutes With John Allen of Coddle Creek Capital, LLC

BUZZ Magazine · John Allen

Images

Coddle Creek Capital photoCoddle Creek Capital photo

Similar investors

Featured in lists